Target intelligence / Profile preview

DLEC1 pseudogene 1 (DLEC1P1)

Target
DLEC1P1
Molecular classification
Other (Pseudogene)
01

Overview

DLEC1 pseudogene 1 (DLEC1P1), also known as deleted in lung and esophageal cancer 1 pseudogene 1, is classified as a pseudogene in the human genome[5][7]. It is a non-protein coding DNA segment that shares sequence similarity with the functional DLEC1 (deleted in lung and esophageal cancer 1) gene but is nonfunctional, meaning it does not encode a protein and has no demonstrated biological or therapeutic function[4][7]. Pseudogenes such as DLEC1P1 can be the result of gene duplication or retrotransposition events, and while most do not produce functional products, some may be transcribed at low levels or participate in gene regulation through RNA-based mechanisms; however, there is currently no evidence for DLEC1P1 having such regulatory roles[4][7]. No clinical, disease, or therapeutic relevance has been established for DLEC1P1, and it is not currently considered a therapeutic target or biomarker.

Other names
deleted in lung and esophageal cancer 1 pseudogene 1
02

Biological functions

None confirmed; pseudogene, likely lacks protein-coding function
03

Disease associations

None confirmed; no established direct disease association for the pseudogene

Beyond the preview

Go deeper on DLEC1 pseudogene 1 (DLEC1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DLEC1 pseudogene 1 (DLEC1P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call